Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials. Lancet Respir Med 2021; 9: 457–66 Interpretation Our findings suggest that efficacy of bronchial thermoplasty is sustained for 10 years or more, with an acceptable safety profile. Therefore, bronchial thermoplasty is a long-acting therapeutic option for patients with asthma that remains uncontrolled despite optimised medical treatment.

Presenta Dra. María José Corrales

19 de julio 2023 16:00hrs / 17:15hrs

Evelijn S Lourijsen, Sietze Reitsma, Marleen Vleming et al. Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial. Lancet Respir Med 2022; 10: 337–46

Presenta Dr. Felipe Cayupi

12 de julio 2023 16:00hrs / 17:15hrs

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022; 399: 1607–17 The findings suggest that segmentectomy should be the standard surgical procedure for this population of patients.

Presenta Dr. Paulo Gnecco

05 de julio 2023 16:00hrs / 17:15hrs

Chest CT–based Assessment of 1-year Outcomes after Moderate COVID-19 Pneumonia. Radiology 2022; 305:479–485

Presenta Dr. Max Kauffmann

28 de junio 2023 16:00hrs / 17:15hrs

Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines. CID 2023:76 (1 February)

Presenta el Dr. Juan Pablo Cuevas

14 de junio 2023 16:00hrs / 17:15hrs